NEW YORK, Oct 26 – Celera blew past analysts’ expectations on Thursday, with first-quarter fiscal 2001 results that beat the street’s estimate by 17 cents a share.

In the company's first fiscal quarter it reported a net loss of $25.7, or 43 cents a share, compared with a net loss of $19.4 million, or 38 cents a share, in the same period a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.